Cargando…

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients

Patients with acute coronary syndrome (ACS) represent a major clinical burden, because they tend to experience recurrent ischemic events. Acute management of patients with ACS includes combination antithrombotic therapy composed of a parenteral anticoagulant and dual-antiplatelet therapy. Dual-antip...

Descripción completa

Detalles Bibliográficos
Autor principal:	Husted, Steen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337714/ https://www.ncbi.nlm.nih.gov/pubmed/25733842 http://dx.doi.org/10.2147/TCRM.S75024

Ejemplares similares

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Long-term residual cardiovascular risk after acute coronary syndrome: antithrombotic treatment options
por: Chan Pin Yin, D. R. P. P., et al.
Publicado: (2021)

Effect and safety of antithrombotic therapies for secondary prevention after acute coronary syndrome: a network meta-analysis
por: Mo, Fanrui, et al.
Publicado: (2018)

Risk Stratification after an Acute Coronary Syndrome: Significance of Antithrombotic Therapy
por: Brazhnik, Victoria A., et al.
Publicado: (2021)

Evidenced-Based Antithrombotic Therapy for Acute Coronary Syndromes
por: James, Stefan
Publicado: (2013)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
por: Bonanad, Clara, et al.
Publicado: (2022)

Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China
por: Han, Xiao-Ning, et al.
Publicado: (2020)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)

Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome
por: Towashiraporn, Korakoth, et al.
Publicado: (2022)

New Antithrombotic Drugs in Acute Coronary Syndrome
por: Zwart, Bastiaan, et al.
Publicado: (2020)

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
por: Srivastava, Padma
Publicado: (2010)

Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia
por: Huo, Yong, et al.
Publicado: (2021)

Management of antithrombotic therapy in patients at high bleeding risk after percutaneous coronary intervention for acute coronary syndromes: a case report
por: Mahmood, Hamid, et al.
Publicado: (2022)

Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study
por: Knight, Stacey, et al.
Publicado: (2015)

Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations
por: Kwon, Osung, et al.
Publicado: (2022)

Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention
por: Agarwal, Nayan, et al.
Publicado: (2018)

Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome
por: George, Sudhakar, et al.
Publicado: (2019)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes
por: Husted, Steen, et al.
Publicado: (2016)

Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
por: Berger, Jeffrey S.
Publicado: (2018)

Antithrombotic Therapy in the Prevention of Stroke
por: Bir, Shyamal, et al.
Publicado: (2021)

Variability of Antithrombotic Dosing Among Veterans Presenting With Acute Coronary Syndrome
por: Plomondon, Mary E., et al.
Publicado: (2015)

Long‐term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2‐year observations from the EPICOR Asia study
por: Zheng, Bo, et al.
Publicado: (2020)

Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary syndrome
por: Mischie, Alexandru Nicolae, et al.
Publicado: (2017)

Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
por: Limbruno, Ugo, et al.
Publicado: (2020)

Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice
por: Yan, Yan, et al.
Publicado: (2017)

Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study
por: Sawhney, J.P.S., et al.
Publicado: (2019)

Chinese expert consensus on antithrombotic management of high‐risk elderly patients with chronic coronary syndrome
por: Zhang, Cuntai, et al.
Publicado: (2023)

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
por: Parikh, Shailja V, et al.
Publicado: (2009)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study
por: Lee, Chiao-Chin, et al.
Publicado: (2021)

Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?
por: Lin, Yi-Pin, et al.
Publicado: (2015)

Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Choice of antithrombotics in acute coronary syndrome – A balance of efficacy versus safety
por: Kaul, Upendra, et al.
Publicado: (2016)

Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome
por: Kefer, Joelle, et al.
Publicado: (2022)

Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study
por: Chow, Clara K, et al.
Publicado: (2019)

Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long‐Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study
por: Guan, Shaoyi, et al.
Publicado: (2020)

Update on Antithrombotic Therapy after Percutaneous Coronary Intervention
por: Saito, Yuichi, et al.
Publicado: (2019)

Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy–An observational study
por: Holm, Anna, et al.
Publicado: (2021)

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
por: Pocock, Stuart, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3cr6mmq868mtdilo6p9nvicjto